Cytokine‐Enhanced Vaccine as Surgery Adjuvant Treatment for Spontaneous Canine Melanoma: Comparison of Two Intralesional Procedures for Local Disease Control | ||
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Dr. Ángel Roffo". Unidad de Transferencia Genética | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Dr. Ángel Roffo". Unidad de Transferencia Genética | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Dr. Ángel Roffo". Unidad de Transferencia Genética | |
| dc.contributor.author | Finocchiaro, Liliana Maria Elena | |
| dc.contributor.author | Villaverde, Marcela Solange | |
| dc.contributor.author | Glikin, Gerardo Claudio | |
| dc.date.issued | 2026-04 | |
| dc.description.abstract | We present here the feasibility, safety, and efficacy results of a 7-year study that included 337 canine melanoma patients undergoing surgery with adjuvant intralesional therapies combined with immunogenic therapy. After complete (CS) or partial (PS) surgery, the patients received post-surgical bed injections of (i) lipoplexes carrying canine interferon-β (cIFNβ) gene combined with bleomycin (CTIF/B) or (ii) 5-fluorouracil (CT5FU). This surgery adjuvant therapy (SAT) also included the periodic administration of subcutaneous genetic vaccines composed of tumour extracts and lipoplexes carrying cIFNβ, human interleukin-2, and human granulocyte-macrophage colony-stimulating factor genes. Compared at the end of their individual follow-ups with controls treated with complete surgery alone (CSo), CS-CTIF/B and CS-CT5FU treatments quadrupled the fraction of local disease-free (from 19% to 81% and 85%), and increased the percentage of metastasis-free patients (M0: from 47% to 82% and 81%). Both PS arms (PS-CTIF/B and PS-CT5FU) also significantly increased the fraction of metastatic-free disease (M0: from 48% to 75% and 73%). In addition, SAT produced a significant 11- (CS-CTIF/B: p < 0.0001, HR95% CI = 0.155 [0.109–0.222]), 9- (CS-CT5FU: p < 0.0001, HR95% CI = 0.172 [0.123–0.242]), 6- (PS-CTIF/B: p < 0.0001, HR95% CI = 0.204 [0.132–0.315]), and 7- (PS-CT5FU: p < 0.0001, HR95% CI = 0.203 [0.132–0.311]) fold increase of overall survival as compared to their respective CSo and PSo controls. The respective median follow-up days for each group were: 695.5 (28-2516), 542.5 (46-2554), 458 (29-1273), and 521 (30-1659). In general terms, this SAT transformed a lethal disease into a manageable condition where 25% (CS-CTIF/B), 24% (CS-CT5FU), 22% (PS-CTIF/B), and 22% (PS-CT5FU) of patients were still alive at the end of the study, while 53%, 60%, 16%, and 17%, respectively, died from causes unrelated to melanoma. Both surgery adjuvant treatments delayed or prevented post-surgical recurrence and metastases, improved disease-free and overall survival while maintaining quality of life. These successful outcomes encourage assaying a similar scheme for human melanoma. | es |
| dc.description.fil | Fil: Finocchiaro, Liliana Maria Elena. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Dr. Ángel Roffo". Unidad de Transferencia Genética; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.description.fil | Fil: Villaverde, Marcela Solange. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Dr. Ángel Roffo". Unidad de Transferencia Genética; Argentina | |
| dc.description.fil | Fil: Glikin, Gerardo Claudio. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Dr. Ángel Roffo". Unidad de Transferencia Genética; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Finocchiaro, Liliana Maria Elena; Villaverde, Marcela Solange; Glikin, Gerardo Claudio; Cytokine‐Enhanced Vaccine as Surgery Adjuvant Treatment for Spontaneous Canine Melanoma: Comparison of Two Intralesional Procedures for Local Disease Control; Wiley Blackwell Publishing, Inc; Veterinary And Comparative Oncology; 4-2026; 1-16 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1476-5810 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/294305 | |
| dc.journal.ciudad | Londres | es |
| dc.journal.pagination | 1-16 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Veterinary And Comparative Oncology | es |
| dc.language.iso | eng | es |
| dc.publisher | Wiley Blackwell Publishing, Inc | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1111/vco.70072 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1111/vco.70072 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | cytokine enhanced vaccine | es |
| dc.subject | canine melanoma | es |
| dc.subject | surgery | es |
| dc.subject.classification | Otras Ciencias de la Salud | es |
| dc.subject.classification | Ciencias de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Cytokine‐Enhanced Vaccine as Surgery Adjuvant Treatment for Spontaneous Canine Melanoma: Comparison of Two Intralesional Procedures for Local Disease Control | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.38b38670-a3d6-4a8f-9dc0-d763b7c2005c_E.pdf
- Tamaño:
- 918.47 KB
- Formato:
- Adobe Portable Document Format
- Descripción: